373 related articles for article (PubMed ID: 26956417)
1. Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence.
Holowka T; Castilho TM; Garcia AB; Sun T; McMahon-Pratt D; Bucala R
FASEB J; 2016 Jun; 30(6):2249-65. PubMed ID: 26956417
[TBL] [Abstract][Full Text] [Related]
2. A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses.
Kamir D; Zierow S; Leng L; Cho Y; Diaz Y; Griffith J; McDonald C; Merk M; Mitchell RA; Trent J; Chen Y; Kwong YK; Xiong H; Vermeire J; Cappello M; McMahon-Pratt D; Walker J; Bernhagen J; Lolis E; Bucala R
J Immunol; 2008 Jun; 180(12):8250-61. PubMed ID: 18523291
[TBL] [Abstract][Full Text] [Related]
3. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection.
Satoskar AR; Bozza M; Rodriguez Sosa M; Lin G; David JR
Infect Immun; 2001 Feb; 69(2):906-11. PubMed ID: 11159984
[TBL] [Abstract][Full Text] [Related]
4. Both host and parasite MIF molecules bind to chicken macrophages via CD74 surface receptor.
Kim S; Cox CM; Jenkins MC; Fetterer RH; Miska KB; Dalloul RA
Dev Comp Immunol; 2014 Dec; 47(2):319-26. PubMed ID: 25086294
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.
Fan H; Hall P; Santos LL; Gregory JL; Fingerle-Rowson G; Bucala R; Morand EF; Hickey MJ
J Immunol; 2011 Apr; 186(8):4915-24. PubMed ID: 21411731
[TBL] [Abstract][Full Text] [Related]
6. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
[TBL] [Abstract][Full Text] [Related]
7. The Phosphoenolpyruvate Carboxykinase Is a Key Metabolic Enzyme and Critical Virulence Factor of
Barazandeh AF; Mou Z; Ikeogu N; Mejia EM; Edechi CA; Zhang WW; Alizadeh J; Hatch GM; Ghavami S; Matlashewski G; Marshall AJ; Uzonna JE
J Immunol; 2021 Mar; 206(5):1013-1026. PubMed ID: 33462138
[TBL] [Abstract][Full Text] [Related]
8. Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment.
Zhang M; Yan L; Kim JA
Cancer Gene Ther; 2015 Oct; 22(10):463-74. PubMed ID: 26403072
[TBL] [Abstract][Full Text] [Related]
9. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.
Jüttner S; Bernhagen J; Metz CN; Röllinghoff M; Bucala R; Gessner A
J Immunol; 1998 Sep; 161(5):2383-90. PubMed ID: 9725234
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.
Malu DT; Bélanger B; Desautels F; Kelendji K; Dalko E; Sanchez-Dardon J; Leng L; Bucala R; Satoskar AR; Scorza T
J Immunol; 2011 Jun; 186(11):6271-9. PubMed ID: 21518974
[TBL] [Abstract][Full Text] [Related]
11. MIF signal transduction initiated by binding to CD74.
Leng L; Metz CN; Fang Y; Xu J; Donnelly S; Baugh J; Delohery T; Chen Y; Mitchell RA; Bucala R
J Exp Med; 2003 Jun; 197(11):1467-76. PubMed ID: 12782713
[TBL] [Abstract][Full Text] [Related]
12. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
13. Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer.
Klemke L; De Oliveira T; Witt D; Winkler N; Bohnenberger H; Bucala R; Conradi LC; Schulz-Heddergott R
Cell Death Dis; 2021 Feb; 12(2):155. PubMed ID: 33542244
[TBL] [Abstract][Full Text] [Related]
14. CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major.
Ishikawa H; Hisaeda H; Taniguchi M; Nakayama T; Sakai T; Maekawa Y; Nakano Y; Zhang M; Zhang T; Nishitani M; Takashima M; Himeno K
Int Immunol; 2000 Sep; 12(9):1267-74. PubMed ID: 10967021
[TBL] [Abstract][Full Text] [Related]
15. Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8+ T cells do not mediate a protective immune response.
Erb K; Blank C; Ritter U; Bluethmann H; Moll H
Immunobiology; 1996 Jul; 195(2):243-60. PubMed ID: 8877400
[TBL] [Abstract][Full Text] [Related]
16. MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major.
Lemos MP; Esquivel F; Scott P; Laufer TM
J Exp Med; 2004 Mar; 199(5):725-30. PubMed ID: 14993255
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.
Ohta S; Misawa A; Fukaya R; Inoue S; Kanemura Y; Okano H; Kawakami Y; Toda M
J Cell Sci; 2012 Jul; 125(Pt 13):3210-20. PubMed ID: 22454509
[TBL] [Abstract][Full Text] [Related]
18. The Smad3-miR-29b/miR-29c axis mediates the protective effect of macrophage migration inhibitory factor against cardiac fibrosis.
Liang JN; Zou X; Fang XH; Xu JD; Xiao Z; Zhu JN; Li H; Yang J; Zeng N; Yuan SJ; Pan R; Fu YH; Zhang M; Luo JF; Wang S; Shan ZX
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2441-2450. PubMed ID: 31175931
[TBL] [Abstract][Full Text] [Related]
19. Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium.
Xu D; McSorley SJ; Tetley L; Chatfield S; Dougan G; Chan WL; Satoskar A; David JR; Liew FY
J Immunol; 1998 Feb; 160(3):1285-9. PubMed ID: 9570545
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor regulates innate γδ T-cell responses
Kim HK; Garcia AB; Siu E; Tilstam P; Das R; Roberts S; Leng L; Bucala R
FASEB J; 2019 Jun; 33(6):6919-6932. PubMed ID: 30817226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
